Pharmacare negotiations between the Liberals and NDP are on a knife’s edge, and the main point of contention is the number of drugs they plan to start with.
If the parties reach a deal, they plan to begin by launching with a select few drug categories while they continue to formulate a more robust national drug plan, two sources with knowledge of the talks said.